Impact of Cancer Therapy-Related Cardiac Dysfunction on Risk of Heart Failure in Pregnancy

Impact of Cancer Therapy-Related Cardiac Dysfunction on Risk of Heart Failure in Pregnancy

Background: Cancer treatment can lead to left ventricular (LV) dysfunction in female cancer survivors of reproductive age, and pregnancy-related hemodynamic stress may result in LV dysfunction or heart failure (HF). Objectives: We performed a systematic review and meta-analysis to determine the inci...

Full description

Bibliographic Details
Main Authors:	Mark Nolan, MBBS, PhD, Evangelos K. Oikonomou, MD, Candice K. Silversides, MD, Melissa R. Hines, MD, Kara A. Thompson, MD, Belinda A. Campbell, MBBS, MMed, Eitan Amir, MD, PhD, Cynthia Maxwell, MD, Paaladinesh Thavendiranathan, MD, SM
Format:	Article
Language:	English
Published:	Elsevier 2020-06-01
Series:	JACC. CardioOncology
Subjects:	cancer survivors cancer therapeutics-related cardiac dysfunction cardiotoxicity heart failure pregnancy
Online Access:	http://www.sciencedirect.com/science/article/pii/S2666087320300752

Similar Items

Cardiac Disease in Childhood Cancer Survivors
by: Jan M. Leerink, MD, et al.
Published: (2020-09-01)

At the Heart of Safe and Successful Pregnancies in Cancer Survivors∗
by: Melissa M. Hudson, MD, et al.
Published: (2020-06-01)

Working Together to Advance Cardio-Oncology in China
by: Yunlong Xia, MD, PhD, et al.
Published: (2020-03-01)

Cardio-Oncology in Israel
by: Zaza Iakobishvili, MD, PhD, et al.
Published: (2019-12-01)

Increased Cancer Prevalence in Peripartum Cardiomyopathy
by: Tobias J. Pfeffer, MD, et al.
Published: (2019-12-01)

Cardio-Oncology and the Intersection of Cancer and Cardiotoxicity
by: Richard K. Cheng, MD, MSc, et al.
Published: (2019-12-01)

The Evolving Design of NIH-Funded Cardio-Oncology Studies to Address Cancer Treatment-Related Cardiovascular Toxicity
by: Lori M. Minasian, MD, et al.
Published: (2019-09-01)

The Establishment of the Nordic Cardio-Oncology Society
by: Agneta Månsson Broberg, MD, PhD, et al.
Published: (2020-06-01)

Targeting the Cardiotoxicity of Epidermal Growth Factor Receptor Inhibitors∗
by: Dipesh Uprety, MBBS, et al.
Published: (2020-03-01)

Cardiotoxicity Surveillance and Risk of Heart Failure During HER2 Targeted Therapy
by: Anthony F. Yu, MD, et al.
Published: (2020-06-01)

Early Detection and Prediction of Anthracycline-Induced Right Ventricular Cardiotoxicity by 3-Dimensional Echocardiography
by: Rui Zhao, MBBS, et al.
Published: (2020-03-01)

Osimertinib-Induced Cardiotoxicity
by: Kartik Anand, MD, et al.
Published: (2019-12-01)

Immune Checkpoint Inhibitor-Related Adverse Cardiovascular Events in Patients With Lung Cancer
by: Kalyan R. Chitturi, DO, et al.
Published: (2019-12-01)

Heart Failure Associated With the Epidermal Growth Factor Receptor Inhibitor Osimertinib
by: Andrew J. Piper-Vallillo, MD, et al.
Published: (2020-03-01)

Pregnancy and Cardiomyopathy After Anthracyclines in Childhood
by: Kara Annette Thompson
Published: (2018-03-01)

Efficacy of Dexrazoxane in Preventing Anthracycline Cardiotoxicity in Breast Cancer
by: Ariane V.S. Macedo, MD, MSc, et al.
Published: (2019-09-01)

Cardio-Oncology in China
by: Yuhui Zhang, MD, et al.
Published: (2020-03-01)

21st Century Cardio-Oncology
by: Calvin Chen Sheng, MD, et al.
Published: (2016-08-01)

Evidence-based prediction and prevention of cardiovascular morbidity in adults treated for cancer
by: Renske Altena, et al.
Published: (2021-05-01)

Immune Checkpoint Inhibitor–Related Cardiovascular Toxicity in Lung Cancer
by: Lova Sun, MD, et al.
Published: (2019-12-01)

Development of a Cardio-Oncology Program in a Community Hospital
by: Deborah W. Sundlöf, DO, et al.
Published: (2019-12-01)

Prognostic Markers and Valve Therapy
by: Paul Sorajja, MD, et al.
Published: (2019-12-01)

Symptomatic Heart Failure in Acute Leukemia Patients Treated With Anthracyclines
by: Yu Kang, MD, PhD, et al.
Published: (2019-12-01)

Examining Cardiotoxicity With HER2 Therapies∗
by: Neelima Denduluri, MD
Published: (2020-06-01)

Myocardial and Pericardial Toxicity Associated With Immune Checkpoint Inhibitors in Cancer Patients
by: Johnny Chahine, MD, et al.
Published: (2020-02-01)

Effects of Cognitive Status on Life Participation of Cancer Survivors
by: Mary F. Baxter PhD, OT, FAOTA, et al.
Published: (2014-04-01)

Efficacy of Neurohormonal Therapies in Preventing Cardiotoxicity in Patients With Cancer Undergoing Chemotherapy
by: Muthiah Vaduganathan, MD, MPH, et al.
Published: (2019-09-01)

Nurses Supporting Cancer Survivors with the Self-Management of Symptoms
by: Kelly, Freya
Published: (2017)

Repeated Remote Ischemic Conditioning Protects Against Doxorubicin Cardiotoxicity
by: Derek J. Hausenloy, MD, PhD, et al.
Published: (2020-03-01)

Role of NT-proBNP in detection of myocardial damage in childhood leukemia survivors treated with and without anthracyclines
by: Mladosievicova Beata, et al.
Published: (2012-10-01)

A Case of Lung Adenocarcinoma Harboring a Rare LOC285000-ALK-NCK2 Gene Fusion Identified by Next-Generation Sequencing With Long-Term Response to Crizotinib
by: Min Zhang, MBBS, et al.
Published: (2021-02-01)

Preventing the Cancer Patient of Today From Becoming the Heart Failure Patient of Tomorrow∗
by: Derek M. Yellon, PhD, DSc, et al.
Published: (2019-12-01)

Proton Beam Therapy for Thymic Carcinoma with Pericardial Involvement
by: Pierre Loap, MSc, et al.
Published: (2020-11-01)

Quantifying arrhythmic long QT effects of hydroxychloroquine and azithromycin with whole-heart optical mapping and simulations
by: Ilija Uzelac, PhD, MBA, et al.
Published: (2021-08-01)

Osimertinib-Induced Cardiomyopathy
by: Shruti R. Patel, MD, et al.
Published: (2020-04-01)

Pre-Diagnosis Exercise and Cardiovascular Events in Primary Breast Cancer
by: Tochi M. Okwuosa, DO, et al.
Published: (2019-09-01)

Using Behavioral Economics and Technology to Improve Outcomes in Cardio-Oncology
by: Kimberly J. Waddell, PhD, et al.
Published: (2020-03-01)

Pembrolizumab Plus Amrubicin in Patients With Relapsed SCLC: Multi-Institutional, Single-Arm Phase 2 Study
by: Hiroaki Akamatsu, MD, PhD, et al.
Published: (2021-07-01)

Magnetic Resonance Imaging to Detect Cardiovascular Effects of Cancer Therapy
by: Iwan Harries, MBBCh, et al.
Published: (2020-06-01)

Skip Soft Definitions and Focus on Hard Endpoints∗
by: Juan C. Lopez-Mattei, MD, et al.
Published: (2019-12-01)